Aims The study was conducted to determine whether the method for selecting cases of
venous thromboembolism (VTE) from general practice databases significantly affected the …

Objectives To investigate the factors associated with idiopathic venous thromboembolism in
combined oral contraceptive users and to estimate the crude and age-specific incidence …

The annual incidence of diagnosed venous thromboembolism (VTE) is 1 to 2 events per
1000 of the general population. VTE is very uncommon before age 20 years and, after 40 …

Names: King, Bruce M., author.| Regan, Pamela C., author. Title: Human sexuality
today/Bruce M. King, Pamela C. Regan. Description: 9th edition.| Hoboken, NJ …

Gaubius Laboratory TNO-PG, Leiden, The Netherlands! ntroduction minimal changes
(avoiding the interpretation)(8). During the second meeting in Amsterdam in 1995 it was …

Introduction Currently available combined oral contraceptives (COC) reportedly increase the
risk of venous thromboembolism (VTE). We aimed to quantify this risk considering both …

OBJECTIVE: This review was conducted to show the full range of incidence estimates
published for venous thromboembolism (VTE) in women depending on study design and to …

Objective: To compare the risk of idiopathic venous thromboembolism among women taking
third generation oral contraceptives (with gestodene or desogestrel) with that among women …

OBJECTIVE: To assess the relationship between venous thromboembolic disease (VTE)
and use of low-estrogen dose (< 50 μg) combined estrogen-progestin oral contraceptives …

Background Previous studies have been interpreted as suggesting an increase in risk of
cancer among users of calcium-channel blockers compared with users of β-blockers. To …